The #1 Medical Tourism Platform since 2014
Patient Safety
Patient Safety

Best Lung cancer oncologists in Turkey: TOP 43 doctors

author
Content meets the Bookimed Editorial Policy and is medically reviewed by
Fahad Mawlood - General practitioner. Winner of 4 scientific awards. Served in Western Asia. Former Team Leader of a medical team supporting Arabic-speaking patients. Now responsible for data processing and medical content accuracy.
Şeref Kömürcü
Şeref Kömürcü
Clinical oncologist
32 years of experience
4.6
493 reviews
Turkey, Istanbul
Anadolu Medical Center

Şeref Kömürcü

Clinical oncologist
32 years of experience

accreditations:

The American Society of Clinical Oncology
The European Society For Medical Oncology
ECFMG

Prof. Şeref Kömürcü is an ECFMG and ESMO-certified medical and breast oncologist with over 20 years of experience. He specializes in solid cancer, breast cancer, colorectal and lung cancer treatment and has held teaching and scientific positions throughout his career. He is a member of several professional organizations.

Read more
4.6
493 reviews
Doctor's visit price on request
Da Vinci Robotic Sy $24000
Stereotaxic radiosurgery $600 - $850
Radiotherapy for lung cancer $12000 - $18000
More treatments
Info
Altan Kır
Altan Kır
4.6
493 reviews
Turkey, Istanbul
Anadolu Medical Center

accreditations:

European Society of Thoracic Surgeons

Assoc.Prof. Altan Kır is a Thoracic Surgery and Robotic Surgery specialist, as well as one of the top lung cancer doctors. He has been a thoracic surgeon at Anadolu Medical Center since 2007 and is a member of the Turkish Thoracic Surgery Society, the European Society of Thoracic Surgeons, and the Thorax Society.

Read more
4.6
493 reviews
Doctor's visit price on request
Da Vinci Robotic Sy $24000
Stereotaxic radiosurgery $600 - $850
Radiotherapy for lung cancer $12000 - $18000
More treatments
Info
Necdet Uskent
Necdet Uskent
4.6
493 reviews
Turkey, Istanbul
Anadolu Medical Center
Dr. Uskent is an experienced doctor with 50+ years of practice in the field of lymphoma and other blood malfunctions. He is known for performing the first in Turkey, and has also practiced in the USA and UK.Read more
4.6
493 reviews
Doctor's visit price on request
Da Vinci Robotic Sy $24000
Stereotaxic radiosurgery $600 - $850
Radiotherapy for lung cancer $12000 - $18000
More treatments
Info
Mustafa Ondzhel
Mustafa Ondzhel
Oncologist/mammologist
23 years of experience
4.5
468 reviews
Turkey, Istanbul
Medipol Mega University Hospital

Mustafa Ondzhel

Oncologist/mammologist
23 years of experience

Professor of oncosurgery and proctology

Read more
4.5
468 reviews
Info
Sezer Saglam
Sezer Saglam
Clinical oncologist
28 years of experience
5.0
36 reviews
Turkey, Istanbul
Istanbul Florence Nightingale Hospital

Sezer Saglam

Clinical oncologist
28 years of experience

accreditations:

ASCO
ESMO

Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.

Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.

Read more
5.0
36 reviews
Info
Turkan Ozturk Topcu
Turkan Ozturk Topcu
Surgical oncologist
17 years of experience
4.7
47 reviews
Turkey, Istanbul
Valued Med Hub Hospitals

Turkan Ozturk Topcu

Surgical oncologist
17 years of experience

Fields of Study and Interests

 Breast Cancer

 Lung Cancer

 Colon Cancer

 Stomach Cancer

 Rectum Cancer

 Ovarian Cancer

 Uterine Cancer

 Liver Cancer

 Esophageal Cancer - Esophagus Cancer

 Kidney Cancer

 Larynx Cancer - Throat Cancer

 Thyroid Cancer

 Head and Neck Cancers

 Gynecological Cancers

 Pancreatic Cancer

 Esophageal Cancer - Esophagus Cancer

 Uterine Cancer

 Brain Cancers - Brain Tumors

 Soft Tissue Cancer - Sarcomas

 Prostate Cancer

 Bladder Cancer

 Bile Duct Cancer

 Testicular Cancer

 Cervical Cancer

 Mouth, Tongue, Lip Cancers

 Gastrointestinal Sy Cancers

 Bone Tumors

 Trachea and Bronchial Cancers

 Skin Cancers - Skin Cancers

 Skeletal Sy Tumors

 Gallbladder Cancer

 Mesothelioma

Education

 Cumhuriyet University Faculty of Medicine, 2004

 Istanbul Haydarpaşa Education and Research Hospital Internal Medicine Specialist, 2010

 Karadeniz Technical University Faculty of Medicine Medical Oncology Specialist, 2015

Career

 MD Andeson Cancer Center, USA, 2008

 Sunnybrook Odette Cancer Center Breast Cancer Clinic, Canada, 2017

 Moffit Cancer Center, USA 2022

 Istanbul Haydarpaşa Education and Research Hospital Internal Medicine, 2010

 İdil State Hospital Internal Medicine Clinic, 2011

 Karadeniz Technical University Faculty of Medicine Medical Oncology Clinic, 2015

 Istanbul Göztepe Education and Research Hospital Medical Oncology Clinic, 2018

 Yeniyüzyıl University Gaziosmanpaşa Hospital Medical Oncology Clinic, 2020

 Ataşehir Medicana Hospital, Medical Oncology Clinic, 2022

Read more
4.7
47 reviews
Doctor's visit price on request
CyberKnife for lung cancer $1641 - $1969
More treatments
Info
Tahsin Ozadli
Tahsin Ozadli
Clinical oncologist
22 years of experience
4.7
47 reviews
Turkey, Istanbul
Valued Med Hub Hospitals

Tahsin Ozadli

Clinical oncologist
22 years of experience

Education and Expertise

Selcuk University Meram Faculty of Medicine - Medical Education

Dr.Abdurrahman Yurtaslan Anakara Oncology Training and Research Hospital Medical Oncology Specialization

 

Experience

Malatya State Hospital Internal Diseases Clinic

Ankara Oncology Hospital Medical Oncology Clinic

Erzurum Regional Training and Research Hospital Medical Oncology Clinic


AREAS OF INTEREST

Lung cancer

esophageal cancer

Gastric cancer

breast cancer

Gastrointestinal surgery

https://scholar.google.com.tr/citations?user=EDuylhoAAAAJ&hl=tr 

Read more
4.7
47 reviews
Doctor's visit price on request
CyberKnife for lung cancer $1641 - $1969
More treatments
Info
Didem Tastekin
Didem Tastekin
Clinical oncologist
20 years of experience
4.7
47 reviews
Turkey, Istanbul
Valued Med Hub Hospitals

Didem Tastekin

Clinical oncologist
20 years of experience

Medical Oncology

 

Fields of Study and Interests

 Gastrointestinal Sy (GI) Cancer

 Cancer Vaccines

 Breast Cancers

 Lung Cancer

 Rare Cancers

 

Education

 MD: Necmettin Erbakan University Meram Faculty of Medicine, 1994

 Internal Medicine Specialist Training: Atatürk University Faculty of Medicine, 2004

 Internal Medicine Specialist Training: Kafkas University Faculty of Medicine, 2007

 Medical Oncology Sub-Specialist Training: Selçuk University Faculty of Medicine, 2010

 Medical Oncology Sub-Specialist Training: Istanbul University Oncology Institute, 2013

 

Career

 Assistant Professor: Atatürk University Faculty of Medicine, 2005

 Assist. Prof. Dr.: Kafkas University, 2006-2007

 Minor Assistant Professor: Selçuk University – Medical Oncology, 2007-2010

 Minor Assistant Professor: Istanbul University Oncology Institute – Medical Oncology,

2012-2013

 Specialist Professor: Istanbul University Oncology Institute – Medical Oncology, 2013-2017

 Assoc. Prof. Dr.: Istanbul University Oncology Institute – Medical Oncology, 2017-2023

 Prof. Dr.: Istanbul University Oncology Institute – Medical Oncology, 2023-present

Read more
4.7
47 reviews
Doctor's visit price on request
CyberKnife for lung cancer $1641 - $1969
More treatments
Info
Mustafa Serkan Alemdar
Mustafa Serkan Alemdar
Clinical oncologist
19 years of experience
3.0
1 review
Turkey, Antalya
Medical Park Antalya Hospital Complex

Mustafa Serkan Alemdar

Clinical oncologist
19 years of experience

Education and Specialization

  • 2006: Kocaeli University Faculty of Medicine
  • 2014: Akdeniz University Faculty of Medicine, Internal Medicine
  • 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

  • 2006 - 2008: Konya Derebucak District Hospital
  • 2009 - 2015: Akdeniz University Hospital
  • 2015: Antalya Kaş State Hospital
  • 2015 - 2016: İnönü University Faculty of Medicine
  • 2016 - 2021: Akdeniz University Hospital
  • 2021 - 2023: Antalya Training and Research Hospital
Read more
3.0
1 review
Info
Senem Karabulut
Senem Karabulut
Clinical oncologist
15 years of experience
Turkey, Istanbul
Biruni University Hospital

Senem Karabulut

Clinical oncologist
15 years of experience

Education

Istanbul University Cerrahpaşa Faculty of Medicine, 2002
Istanbul Fatih Sultan Mehmet Training and Research Hospital, Internal Medicine, 2010
Istanbul University Oncology Institute (Çapa), Medical Oncology, 2015
Medipol University Faculty of Medicine, Phytotherapy Education, 2018
University of Health Sciences, Vocational School of Health, Molecular Oncology, PhD Program, PhD, 2023

Experience

University Hospital, Newark, New Jersey, USA, Observer (2003-2004)
Siirt State Hospital, Internal Medicine (2010-2011)
Siirt State Hospital, Medical Oncology (2015)
Bakırköy Dr. Sadi Konuk Training and Research Hospital, Medical Oncology (2015-2018)
Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Medical Oncology, (Professor Doctor) (2018-Present)
Forensic Medicine 3. Specialization Board, Medical Oncology, Full Member (2019-Present)
Liv Hospital, Ulus, Park-time, Medical Oncology (2020-2022)
Şişli Kolan International Hospital, Park-time, Medical Oncology (2022-2023)

 

Medical Intrests

  • Gastrointestinal Sy Tumours (Esophagus - Stomach and Large Bowel Cancer)
  • Hepatobiliary Sy Tumours (Liver-Biliary Tract and Pancreatic Cancer)
  • Breast Cancer
  • Lung Cancer
  • Genitourinary Cancers
  • Immunotherapies and Target Therapies
  • Molecular Oncology
  • Immunotherapies
  • Target Treatments
  •  

Awards

2010-YDUS (Subspecialty Examination) 14th place in Turkey
2014- Oncology Institute Days Best Poster Award
2015- Turkish Medical Oncology Society Board Exam Qualification
2015- ESMO (European Society for Medical Oncology) Board Exam Qualification

Read more
Info
Turkan Ozturk Topcu
Turkan Ozturk Topcu
Clinical oncologist
15 years of experience
Turkey, Istanbul
Biruni University Hospital

Turkan Ozturk Topcu

Clinical oncologist
15 years of experience

Education

Cumhuriyet University Faculty of Medicine, 2004
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine Residency, 2010
Karadeniz Technical University Faculty of Medicine Medical Oncology Residency, 2015

Experience

MD Andeson Cancer Center, USA, 2008
Sunnybrook Odette Cancer Center Breast Cancer Clinic, Canada, 2017
Moffit Cancer Center , USA 2022
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine, 2010
İdil State Hospital Internal Medicine Clinic, 2011
Karadeniz Technical Universityniversitesi Faculty of Medicine, Medical Oncology Clinic, 2015
Istanbul Göztepe Training and Research Hospital, Medical Oncology Clinic, 2018
Yeniyüzyıl University Gaziosmanpaşa Hospital, Medical Oncology Clinic, 2020
Ataşehir Medicana Hospital, Medical Oncology Clinic, 2022

 

Scientific Membership

Turkish Medical Association (TTB)
Turkish Society of Medical Oncology (TTOD)
European Society for Medical Oncology (ESMO)
American Society of Medical Oncology (ASCO)

 

Medical Intrests

  • Breast Cancer
  • Lung Cancer
  • Colon Cancer
  • Stomach Cancer
  • Rectal Cancer
  • Ovarian Cancer
  • Liver Cancer
  • Oesophageal Cancer - Oesophageal Cancer
  • Kidney Cancer
  • Larynx Cancer - Cancer of the Larynx
  • Thyroid Cancer
  • Head and Neck Cancers
  • Gynaecological Cancers
  • Pancreatic Cancer
  • Oesophageal Cancer - Oesophageal Cancer
  • Uterine Cancer
  • Brain Cancers - Brain Tumours
  • Soft Tissue Cancer - Sarcomas
  • Prostate Cancer
  • Bladder Cancer
  • Bile Tract Cancer
  • Testicular Cancer
  • Cervical Cancer
  • Mouth, Tongue, Lip Cancers
  • Gastrointestinal Sy Cancers
  • Bone Tumours
  • Trachea and Bronchial Cancers
  • Skin Cancers - Skin Cancers
  • Skeletal Sy Tumours
  • Gallbladder Cancer
  • Mesothelioma
Read more
Info
Nail Paksoy
Nail Paksoy
Oncologist/mammologist
14 years of experience
5.0
2 reviews
Turkey, Istanbul
Medipol Bahçelievler Hospital

Nail Paksoy

Oncologist/mammologist
14 years of experience

accreditations:

ESMO Board Certification in Medical Oncology


PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

 

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

 

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

  • Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
  • Role: Subinvestigator

2. PFİZER

  • Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
  • Role: Subinvestigator

3. RECITE - AMGEN

  • Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
  • Role: Subinvestigator

4. NAVIGATE - BAYER

  • Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
  • Role: Subinvestigator

5. RUBY - Tesaro (PRA)

  • Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
  • Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

  • Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
  • Role: Subinvestigator

7. ASTRA ZENECA

  • Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
  • Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

  • Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
  • Role: Subinvestigator
  •  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

  • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
  • Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

  • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
  • Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

  • Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
  • Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

  • Authors: Paksoy, Nail, et al.
  • Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

  • Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
  • Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

  • Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
  • Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

  • Authors: HAS SIMSEK, Duygu, et al.
  • Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

  • Authors: TURAL, Deniz, et al.
  • Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

  • Authors: FERHATOGLU, Ferhat, et al.
  • Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

  • Authors: TURAL, Deniz, et al.
  • Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

  • Authors: GÜRBÜZ, Mustafa, et al.
  • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

  • Authors: AY, Seval, et al.
  • Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

  • Authors: CIL, Ibrahim, et al.
  • Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

  • Authors: HIZAL, Mutlu, et al.
  • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

  • Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
  • Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

  • Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
  • Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

  • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

  • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
  • Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

  • Authors: DEMIR, Semra, et al.
  • Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

  • Authors: ÖZDEMIR, Seçil Kepil, et al.
  • Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

  • Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
  • Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

  • Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
  • Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

  • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
  • Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

  • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
  • Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

  • Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
  • Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

  • Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
  • Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

  • Authors: Dogan, I., Paksoy, N., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

  • Authors: Dogan, I., Paksoy, N., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

  • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

  • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
  • Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

  • Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
  • Journal: [Not specified]

Efficacy and Outcomes of Syic Chemotherapy in Posttransplant Kaposi Sarcoma

  • Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
  • Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

  • Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
  • Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Syic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

 

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

  • Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

  • Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

  • Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

  • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

  • Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

  • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

  • Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

  • Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

  • Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

  • Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

 

 

Read more
5.0
2 reviews
Doctor's visit price on request
Lobectomy $12000 - $18000
Lung segmentectomy $12000 - $15000
Radiotherapy for lung cancer $4000 - $6000
More treatments
Info
Cemil Bilir
Cemil Bilir
Clinical oncologist
20 years of experience
5.0
1 review
Turkey, Istanbul
VM Medical Park Pendik Hospital

Cemil Bilir

Clinical oncologist
20 years of experience

Education & Expertise

  • 1998 to 2004 – Istanbul University, Istanbul Faculty of Medicine
  • 2005 to 2009 – Düzce University, Internal Medicine Specialization
  • 2009 to 2010 – Beytüşşebap State Hospital, Compulsory Internal Medicine Service
  • 2010 to 2013 – Bülent Ecevit University, Medical Oncology Specialization
  • 2013 to 2015 – Recep Tayyip Erdoğan University, Medical Oncology Compulsory Service
  • 2015 to Present – Associate Professor, Recep Tayyip Erdoğan University
  • 2015 to 2021 – Lecturer, Medical Oncology, Sakarya University Faculty of Medicine
  • 2020 to Present – Professor, Sakarya University Faculty of Medicine
  • 2020 to Present – Ph.D. Student, Inorganic Chemistry, Sakarya University

Experience

  • 2008 – Cleveland Clinic, Rheumatology & Gastroenterology Rotation
  • 2016 to 2017 – Northeastern University, The Center for Pharmaceutical Biotechnology and Nanomedicine, Boston, U.S.

Professional Memberships

  • TTOD (Turkish Society of Medical Oncology)
  • ASCO (American Society of Clinical Oncology)
  • ESMO (European Society for Medical Oncology)
Read more
5.0
1 review
Doctor's visit price on request
Proton-beam therapy $1000 - $1200
More treatments
Info
Osman Kostek
Osman Kostek
Clinical oncologist
21 years of experience
5.0
3 reviews
Turkey, Istanbul
Medipol Acibadem District Hospital

Osman Kostek

Clinical oncologist
21 years of experience

Education

  • (2004 – 2011), Faculty of Medicine/ Inonu University/ Malatya, Turkiye
  • (2011 – 2015), Department of Radiology/ Bagcilar Training and Research Hospital/ Istanbul, Turkiye

Career

  • (2016 – 2020), Diagnostic and Interventional Radiologist/ Mus State Hospital/ Mus,Turkiye
  • (2020 – 2022), Assistant Professor of Diagnostic and Interventional Radiology/ Sakarya University Training and Research Hospital/ Sakarya, Turkiye
  • (2023 – 2024), Associate Professor of Diagnostic and Interventional Radiology /Sakarya University Training and Research Hospital/ Sakarya, Turkiye
  • (2024 - Present), Associate Professor of Diagnostic and Interventional Radiology /Medipol University Hospital/ Istanbul, Turkiye
Read more
5.0
3 reviews
Info
Tahsin Ozatli
Tahsin Ozatli
Clinical oncologist
2015 years of experience
4.3
16 reviews
Turkey, Istanbul
Istinye University Liv Hospital Bahcesehir

Tahsin Ozatli

Clinical oncologist
2015 years of experience
OncologistRead more
4.3
16 reviews
Doctor's visit price on request
Chemotherapy for lung cancer $2000 - $9000
Lobectomy $9453.03 - $12491.5
Lung cancer surgery $10300 - $16400
More treatments
Info
Ferah Ece
Ferah Ece
Pulmonologist
28 years of experience
4.5
229 reviews
Turkey, Istanbul
Liv Hospital Ulus

Ferah Ece

Pulmonologist
28 years of experience
  1. Medical Interests and Activities 
  2. • Lung Cancer (Postdoctoral fellowship, MD Anderson Cancer Center, Houston, TX, USA)
  3. • Interventional Bronchoscopy (Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, USA)
  4.  
  5. Education and Experience 
  6. • Department of Thoracic Diseases, Liv Hospital, Ulus
  7. • Faculty of Medicine, İstanbul Bilim University
  8. • Ministry of Health Süreyyapaşa Thoracic Diseases Training and Research Hospital
  9. • Faculty of Medicine, Marmara University Memberships
  10. • IASLC (International Association for the Study of Lung Cancer)
  11. • ACCP (American College of Chest Physicians)
  12. • TAKD (Turkish Lung Cancer Society) (Executive Board Member)
  13. • TTD (Turkish Thoracic Society)
  14. • TÜSAD (Turkish Respiratory Research Society)
  15.  
  16. Memberships 
  17. • IASLC (International Association for the Study of Lung Cancer) 
  18. • ACCP (American College of Chest Physicians) 
  19. • TAKD (Turkish Lung Cancer Society) (Executive Board Member) 
  20. • TTD (Turkish Thoracic Society) 
  21. • TÜSAD (Turkish Respiratory Research Society) 
  22.  
  23. Researches and Publications 
  24. • International: 48 
  25. • National: 60 
  26. • Authorship for Books and Book Chapters at National Level: 4 
  27. • Medical Fellowship, TEV Orhan Birman, MD 1998 
  28. • “Fellow in American College of Chest Physicians” Title, 2009 
Read more
4.5
229 reviews
Info
Yusuf Acikgoz
Yusuf Acikgoz
Clinical oncologist
9 years of experience
4.7
4 reviews
Turkey, Ankara
Lokman Hekim University Ankara Hospital

Yusuf Acikgoz

Clinical oncologist
9 years of experience

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

  • 2004-2011: İnönü University Faculty of Medicine
  • 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
  • 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

  • 2016-2017: Bingöl City Hospital, Internal Medicine
  • 2021-2022: Health Sciences University, Medical Oncology
  • 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
  • 2023-2024: Ohio State University, Medical Oncology
  • 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

  • 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
  • 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

  • 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
  • 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
  • 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
  • 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
  • 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

  • Ongoing: ECFMG Certification
  • 2024: CITI Responsible Conduct of Research (The Ohio State University)
  • 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
  • 2024: CITI Human Subjects Protection (The Ohio State University)
  • 2024: CITI Good Clinical Practice (The Ohio State University)
  • 2023: Occupational English Test (OET)
  • 2019: International English Language Testing Sy (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
  • 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
  • 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

  • American Society of Clinical Oncology (ASCO) - 2022
  • Turkish Society of Medical Oncology - 2020
Read more
4.7
4 reviews
Info
Seyda Gunduz
Seyda Gunduz
Clinical oncologist
15 years of experience
4.3
16 reviews

Seyda Gunduz

Clinical oncologist
15 years of experience
Turkey, Istanbul
Istinye University Liv Hospital Bahcesehir
4.3
16 reviews
Doctor's visit price on request
Chemotherapy for lung cancer $2000 - $9000
Lobectomy $9453.03 - $12491.5
Lung cancer surgery $10300 - $16400
More treatments
Info
Didem Karacetin
Didem Karacetin
Radiation oncologist
31 years of experience
Turkey, Istanbul
Biruni University Hospital

Didem Karacetin

Radiation oncologist
31 years of experience

Education

  • Faculty of Medicine: Trakya University, 1982-1988
  • Radiation Oncology Residency: Şişli Etfal Training and Research Hospital, 1994-1998
  • Radiation Oncology Residency: Princess Margaret Hospital Toronto, 1996
  • Phytotherapy Master's Degree: Istanbul University Faculty of Pharmacy, 2017-2018

Experience

  • Professor, Head of Department: Health Sciences University Bursa Faculty of Medicine, Department of Radiation Oncology, 2021-2024
  • Professor, Head of Department: Health Sciences University Izmir Faculty of Medicine, Department of Radiation Oncology, 2021-2024
  • Professor: Department of Radiation Oncology, Health Sciences University Istanbul Hamidiye Faculty of Medicine, 2021-2024
  • Lecturer Gelisim University SMYO, 2013-2020

 

Medical Interests

  • Breast Cancer / Intraoperative Radiotherapy
  • Gynaecological Cancers / Brachytherapy Applications
  • Gastrointestinal Sy Tumours
  • Prostate Cancer / Hydrogel Space Oar Certificate and Application
  • Lung Cancers
  • Brain Tumours
  • Head and Neck Cancers
Read more
Info
Tarik Salman
Tarik Salman
Clinical oncologist
31 years of experience
Turkey, İzmir
Medicalpoint International Hospital

Tarik Salman

Clinical oncologist
31 years of experience

Diseases

  • Lung Cancer
  • Skin Cancers
  • Gastrointestinal Cancers
  • Genitourinary Cancers
  • Gynecological Cancers
  • Colon Cancer
  • Breast Cancer
  • Rare Cancers

Treatment Methods

  • Individual Treatments (Comprehensive Genomic Profiling)
  • Targeted Therapies
  • Immunotherapy
  • Cancer Vaccines
  • Chemotherapy
  • Clinical Research/Experimental Medical Research

Experience

  • 2017- 2024: Katip Çelebi University Faculty of Medicine Atatürk Education and Research Hospital Medical Oncology Clinic Associate Professor / Lecturer
  • 2022 December – 2023 March: Academic visitor Moffitt Cancer Center Cutaenous Oncology Clinic Tampa, Florida USA
  • 2013- 2017: Katip Çelebi University Faculty of Medicine Atatürk Training and Research Hospital – Medical Oncology Clinic Specialist Physician
  • 2012-2013: Izmir Education and Research Hospital, Medical Oncology Specialist Physician
  • 2012-2012: Mersin State Hospital, Medical Oncology Specialist Physician
  • 2010-2012: Dokuz Eylül University Faculty of Medicine, Department of Medical Oncology, Sub-branch Research Assistant
  • June-August 2008, December 2008 – February 2009: Memorial Sloan Kettering Cancer Center Observership programme
  • 2007-2009: Kartal Education and Research Hospital, Medical Oncology Sub-branch Research Assistant
  • 2006-2007: Siirt State Hospital, Internal Medicine, Specialist Physician
  • 2005-2006: Çukurova University Faculty of Medicine, Medical Oncology Sub-branch Research Assistant
  • 2004-2005: SSK Siirt Hospital, Internal Medicine Specialist Physician
  • 2003-2004: SSK Mardin Hospital, Internal Medicine Specialist Physician
  • 1998-2003: SSK Izmir Training and Research Hospital, 3rd Internal Medicine Clinic, Research Assistant
  • 1998-1998: SSK Izmir Training and Research Hospital Infectious Diseases Research Assistant
  • 1997-1998: Izmir Ataturk Training and Research Hospital, Anesthesiology and Reanimation Clinic, Research Assistant
  • 1995-1997: Şırnak Cizre Central Health Center
  • 1994-1995: Şırnak İdil Oyalı Village Health Center

Professional Memberships

  • Turkish Society of Medical Oncology 2008 
  • (2018-2021 Term Board Member)
  • Izmir Oncology Group, Board Member (2014 -…)
  • Geriatric Oncology Association, Board Member (2015-…)
  • Mediterranean Oncology Association Board Member (2020 -…)
  • Turkish Biochemistry Association, Member, 2016
  • European Society of Medical Oncology, Member, 2012
  • American Society of Clinical Oncology, Member, 2008
Read more
Info
This page may feature information relating to various medical conditions, treatments, and healthcare services available in different countries. Please be advised that the content is provided for informational purposes only and should not be construed as medical advice or guidance. Please consult with your doctor or a qualified medical professional before starting or changing medical treatment.

Download Bookimed App to get beauty deals

Bookimed App